Today: 20 March 2026
Subscribe
Browse Category

NSE:RPWR 10 December 2025 - 22 December 2025

Reliance Infrastructure Trading Restricted Under IBC Stage 1 on Dec 22, 2025; Reliance Power Slides as Investors Seek Clarity

Reliance Infrastructure Trading Restricted Under IBC Stage 1 on Dec 22, 2025; Reliance Power Slides as Investors Seek Clarity

Reliance Infrastructure Ltd. was placed under restricted trading linked to the Insolvency and Bankruptcy Code on December 22, 2025, prompting confusion among retail investors and a sharp drop in Reliance Power Ltd. Trading was limited to a “once-a-week” sell-only window on some platforms, with holdings disappearing from certain broker terminals. Liquidity concerns and regulatory uncertainty drove volatility across Anil Ambani-group stocks.
22 December 2025
···
Most Active Indian Stocks Today (10 December 2025): Vodafone Idea, Yes Bank, Suzlon Lead Heavy Trade on NSE

Most Active Indian Stocks Today (10 December 2025): Vodafone Idea, Yes Bank, Suzlon Lead Heavy Trade on NSE

Sensex and Nifty traded flat midday Wednesday, with Sensex near 84,645 and Nifty at 25,839, after sharp declines earlier in the week. Broader indices slipped, led by weakness in PSU banks, while metal, auto, and realty shares outperformed. Vodafone Idea led NSE volumes with over 450 million shares traded. Foreign investors have sold more than $1 billion this month as the rupee hovers near ₹90.4 per dollar.
10 December 2025
·····

Stock Market Today

  • Regeneus Ltd (RGS.AX) Jumps 33% on Heavy Volume, Signals Short-Term Upside
    March 19, 2026, 10:42 PM EDT. Regeneus Ltd (RGS.AX) surged 33.33% to A$0.012 on March 20, 2026, driven by unusually heavy volume of 4.28 million shares, nearly seven times the average. The stock broke above its 50-day and 200-day moving averages, indicating increased short-term trader interest in this clinical-stage biotech focused on osteoarthritis and wound healing. Despite negative earnings per share and liquidity constraints, the price action reflects momentum trading in a volatile sector. Traders should watch intraday support at A$0.010 and resistance near the year high of A$0.020. With a Meyka AI rating of 64.90 (Grade B), the stock is rated HOLD amid high volatility and thin order books typical of small-cap biotechs on the Australian Securities Exchange (ASX).
Go toTop